MedPath

Aspartic acid

Generic Name
Aspartic acid
Brand Names
Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinisol 15, Olimel, Periolimel, Plenamine, Premasol, Primene, Prosol, Trophamine 10 %
Drug Type
Small Molecule
Chemical Formula
C4H7NO4
CAS Number
56-84-8
Unique Ingredient Identifier
30KYC7MIAI

Overview

One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.

Background

One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.

Indication

There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/05/08
N/A
Completed
2025/01/24
Phase 2
Active, not recruiting
2024/10/28
Phase 1
Withdrawn
2024/10/15
Phase 1
Active, not recruiting
Uniquity One (UNI)
2024/06/13
Phase 1
Not yet recruiting
2024/04/11
Phase 3
Recruiting
First Affiliated Hospital of Zhejiang University
2024/03/27
Phase 1
Recruiting
2024/03/25
Not Applicable
Recruiting
2024/01/12
Phase 4
Completed
2023/12/13
Phase 1
Completed

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
ICU Medical Inc.
0990-7171
INTRAVENOUS
1050 mg in 100 mL
5/4/2022
B. Braun Medical Inc.
0264-4500
INTRAVENOUS
434 mg in 100 mL
4/21/2023
Baxter Healthcare Corporation
0338-1131
INTRAVENOUS
0.19 g in 100 mL
8/4/2022
B. Braun Medical Inc.
0264-1933
INTRAVENOUS
0.32 g in 100 mL
8/22/2022
Fresenius Kabi USA, LLC
63323-712
INTRAVENOUS
99 mg in 100 mL
8/2/2023
ICU Medical Inc.
0990-7172
INTRAVENOUS
700 mg in 100 mL
5/4/2022
Fresenius Kabi USA, LLC
63323-714
INTRAVENOUS
71 mg in 100 mL
8/7/2023
ICU Medical Inc.
0990-4178
INTRAVENOUS
370 mg in 100 mL
9/21/2021
Baxter Healthcare Corporation
0338-1130
INTRAVENOUS
0.32 g in 100 mL
8/4/2022
Baxter Healthcare Corporation
0338-0499
INTRAVENOUS
600 mg in 100 mL
10/7/2020

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath